A citation-based method for searching scientific literature

Laetitia Pinte, Amy Cunningham, Helene Trébéden-Negre, Sarah Nikiforow, Jerome Ritz. Front Immunol 2021
Times Cited: 3







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial.
Nirav N Shah, Bryon D Johnson, Dina Schneider, Fenlu Zhu, Aniko Szabo, Carolyn A Keever-Taylor, Winfried Krueger, Andrew A Worden, Michael J Kadan, Sharon Yim,[...]. Nat Med 2020
152
66

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.
David L Porter, Bruce L Levine, Michael Kalos, Adam Bagg, Carl H June. N Engl J Med 2011
66

Chimeric antigen receptor T cells for sustained remissions in leukemia.
Shannon L Maude, Noelle Frey, Pamela A Shaw, Richard Aplenc, David M Barrett, Nancy J Bunin, Anne Chew, Vanessa E Gonzalez, Zhaohui Zheng, Simon F Lacey,[...]. N Engl J Med 2014
66

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia.
Renier J Brentjens, Marco L Davila, Isabelle Riviere, Jae Park, Xiuyan Wang, Lindsay G Cowell, Shirley Bartido, Jolanta Stefanski, Clare Taylor, Malgorzata Olszewska,[...]. Sci Transl Med 2013
66

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.
Renier J Brentjens, Isabelle Rivière, Jae H Park, Marco L Davila, Xiuyan Wang, Jolanta Stefanski, Clare Taylor, Raymond Yeh, Shirley Bartido, Oriana Borquez-Ojeda,[...]. Blood 2011
912
66

Cancer regression in patients after transfer of genetically engineered lymphocytes.
Richard A Morgan, Mark E Dudley, John R Wunderlich, Marybeth S Hughes, James C Yang, Richard M Sherry, Richard E Royal, Suzanne L Topalian, Udai S Kammula, Nicholas P Restifo,[...]. Science 2006
66

Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.
Benjamin Y Jin, Tracy E Campbell, Lindsey M Draper, Sanja Stevanović, Bianca Weissbrich, Zhiya Yu, Nicholas P Restifo, Steven A Rosenberg, Cornelia L Trimble, Christian S Hinrichs. JCI Insight 2018
65
66

Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells.
D Moritz, W Wels, J Mattern, B Groner. Proc Natl Acad Sci U S A 1994
174
33

CD28-ζ CAR T Cells Resist TGF-β Repression through IL-2 Signaling, Which Can Be Mimicked by an Engineered IL-7 Autocrine Loop.
Viktória Golumba-Nagy, Johannes Kuehle, Andreas A Hombach, Hinrich Abken. Mol Ther 2018
46
33


Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells.
Cameron J Turtle, Laïla-Aïcha Hanafi, Carolina Berger, Michael Hudecek, Barbara Pender, Emily Robinson, Reed Hawkins, Colette Chaney, Sindhu Cherian, Xueyan Chen,[...]. Sci Transl Med 2016
640
33

T-cell recognition of human melanoma antigens.
Y Kawakami, M I Nishimura, N P Restifo, S L Topalian, B H O'Neil, J Shilyansky, J R Yannelli, S A Rosenberg. J Immunother Emphasis Tumor Immunol 1993
44
33

Fully human CD19-specific chimeric antigen receptors for T-cell therapy.
D Sommermeyer, T Hill, S M Shamah, A I Salter, Y Chen, K M Mohler, S R Riddell. Leukemia 2017
121
33

Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning.
Hollie J Pegram, James C Lee, Erik G Hayman, Gavin H Imperato, Thomas F Tedder, Michel Sadelain, Renier J Brentjens. Blood 2012
446
33

Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.
Omkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, Lili Guo, Shannon E McGettigan, Avery D Posey, Prachi R Patel, Sonia Guedan, John Scholler, Brian Keith,[...]. Immunity 2016
549
33

A versatile system for rapid multiplex genome-edited CAR T cell generation.
Jiangtao Ren, Xuhua Zhang, Xiaojun Liu, Chongyun Fang, Shuguang Jiang, Carl H June, Yangbing Zhao. Oncotarget 2017
233
33

Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies.
Matthew R Collinson-Pautz, Wei-Chun Chang, An Lu, Mariam Khalil, Jeannette W Crisostomo, Pei-Yi Lin, Aruna Mahendravada, Nicholas P Shinners, Mary E Brandt, Ming Zhang,[...]. Leukemia 2019
38
33

T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells.
A Hombach, J M Muche, M Gerken, S Gellrich, C Heuser, C Pohl, W Sterry, H Abken. Gene Ther 2001
41
33

TGF-β-responsive CAR-T cells promote anti-tumor immune function.
Andrew J Hou, ZeNan L Chang, Michael H Lorenzini, Eugenia Zah, Yvonne Y Chen. Bioeng Transl Med 2018
45
33

Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits.
Kole T Roybal, Levi J Rupp, Leonardo Morsut, Whitney J Walker, Krista A McNally, Jason S Park, Wendell A Lim. Cell 2016
519
33

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.
Daniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, Yongzhi K Cui, Cindy Delbrook, Steven A Feldman, Terry J Fry, Rimas Orentas, Marianna Sabatino, Nirali N Shah,[...]. Lancet 2015
33


Chimeric antigen receptor-T cells with cytokine neutralizing capacity.
Adrian H J Tan, Natasha Vinanica, Dario Campana. Blood Adv 2020
22
33


Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.
Catherine M Bollard, Claudia Rössig, M Julia Calonge, M Helen Huls, Hans-Joachim Wagner, Joan Massague, Malcolm K Brenner, Helen E Heslop, Cliona M Rooney. Blood 2002
247
33

Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma.
Julie R Park, David L Digiusto, Marilyn Slovak, Christine Wright, Araceli Naranjo, Jamie Wagner, Hunsar B Meechoovet, Cherrilyn Bautista, Wen-Chung Chang, Julie R Ostberg,[...]. Mol Ther 2007
417
33

T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours.
Stefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, Adrian Gottschlich, Justyna Ogonek, Bruno L Cadilha, Zahra Dantes, Felicitas Rataj, Klara Dorman, Johannes Lutz,[...]. Nat Biomed Eng 2021
37
33

CAR-T therapy and historical trends in effectiveness and cost-effectiveness of oncology treatments.
James R Baumgardner, Michelle S Brauer, Jie Zhang, Yanni Hao, Zhimei Liu, Darius N Lakdawalla. J Comp Eff Res 2020
6
33

4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.
Adrienne H Long, Waleed M Haso, Jack F Shern, Kelsey M Wanhainen, Meera Murgai, Maria Ingaramo, Jillian P Smith, Alec J Walker, M Eric Kohler, Vikas R Venkateshwara,[...]. Nat Med 2015
894
33

CAR models: next-generation CAR modifications for enhanced T-cell function.
Daniel Abate-Daga, Marco L Davila. Mol Ther Oncolytics 2016
90
33


Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes.
Ignazio Caruana, Barbara Savoldo, Valentina Hoyos, Gerrit Weber, Hao Liu, Eugene S Kim, Michael M Ittmann, Dario Marchetti, Gianpietro Dotti. Nat Med 2015
399
33


Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors.
Nicole M Haynes, Joseph A Trapani, Michèle W L Teng, Jacob T Jackson, Loretta Cerruti, Stephen M Jane, Michael H Kershaw, Mark J Smyth, Phillip K Darcy. Blood 2002
135
33

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.
Barbara Savoldo, Carlos Almeida Ramos, Enli Liu, Martha P Mims, Michael J Keating, George Carrum, Rammurti T Kamble, Catherine M Bollard, Adrian P Gee, Zhuyong Mei,[...]. J Clin Invest 2011
716
33

A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors.
Xiaojun Liu, Raghuveer Ranganathan, Shuguang Jiang, Chongyun Fang, Jing Sun, Soyeon Kim, Kheng Newick, Albert Lo, Carl H June, Yangbing Zhao,[...]. Cancer Res 2016
314
33

CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response.
Nicholas F Kuhn, Terence J Purdon, Dayenne G van Leeuwen, Andrea V Lopez, Kevin J Curran, Anthony F Daniyan, Renier J Brentjens. Cancer Cell 2019
101
33

IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo.
Mythili Koneru, Terence J Purdon, David Spriggs, Susmith Koneru, Renier J Brentjens. Oncoimmunology 2015
259
33





Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice.
Dhanalakshmi Chinnasamy, Zhiya Yu, Sid P Kerkar, Ling Zhang, Richard A Morgan, Nicholas P Restifo, Steven A Rosenberg. Clin Cancer Res 2012
184
33

Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4.
Scott Wilkie, Sophie E Burbridge, Laura Chiapero-Stanke, Ana C P Pereira, Siobhán Cleary, Sjoukje J C van der Stegen, James F Spicer, David M Davies, John Maher. J Biol Chem 2010
124
33


Tumor antigens.
J L Urban, H Schreiber. Annu Rev Immunol 1992
151
33

Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell Therapy.
Sebastian Kobold, Simon Grassmann, Michael Chaloupka, Christopher Lampert, Susanne Wenk, Fabian Kraus, Moritz Rapp, Peter Düwell, Yi Zeng, Jan C Schmollinger,[...]. J Natl Cancer Inst 2015
78
33

Senolytic CAR T cells reverse senescence-associated pathologies.
Corina Amor, Judith Feucht, Josef Leibold, Yu-Jui Ho, Changyu Zhu, Direna Alonso-Curbelo, Jorge Mansilla-Soto, Jacob A Boyer, Xiang Li, Theodoros Giavridis,[...]. Nature 2020
260
33


T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitope.
A Hombach, C Heuser, R Sircar, T Tillmann, V Diehl, W Kruis, C Pohl, H Abken. Gastroenterology 1997
58
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.